Loading...
•
Dec 31, 2020
Allscripts Q4 2020 Earnings Report
Allscripts reported strong Q4 2020 earnings, driven by strategic actions and portfolio optimization, including revenue of $386 million, GAAP EPS of $4.82, and non-GAAP EPS of $0.29.
Key Takeaways
Allscripts' Q4 2020 results demonstrated continued progress with revenue of $386 million and non-GAAP revenue of $415 million. The company reported a GAAP EPS of $4.82 and a non-GAAP EPS of $0.29, driven by strategic actions and portfolio optimization. The company closed sales of EPSi and CarePort Health, repurchased $280 million of stock, and ended the quarter in a net cash position.
Allscripts' Q4 GAAP revenue was $386 million, while non-GAAP revenue was $415 million.
GAAP net income totaled $728 million, and non-GAAP net income was $45 million.
The company reported GAAP EPS of $4.82 and non-GAAP diluted EPS of $0.29.
Allscripts repurchased $280 million of stock and closed sales of EPSi and CarePort Health.
Revenue by Segment
Forward Guidance
For the full year 2021, Allscripts expects to achieve revenue of $1.5 billion, adjusted EBITDA between $240 million and $260 million, and free cash flow between $90 million and $100 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...